RCM
ABMD

Reynolds Capital Management’s Abiomed Inc ABMD Stock Holding History

Reynolds Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,800
Closed -$352K – 165
2015
Q3 		$352K Buy
+3,800
New +$335K 0.44% 80

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $254M AUM 4.59% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Reynolds Capital Management's ABMD Position: Q4 2015 in Review

Reynolds Capital Management sold out of Abiomed Inc (ABMD) in Q4 2015, closing a stake of 3,800 shares — an estimated $352K sold.

Reynolds Capital Management first reported a position in ABMD in Q3 2015 and held it in 1 quarter. The position peaked at $352K in Q3 2015. 249 funds tracked by Wall St. Rank hold ABMD as of Q4 2015.

  • Reynolds Capital Management reported no remaining Abiomed Inc position as of Q4 2015 after selling out during the quarter.
  • Reynolds Capital Management sold 3,800 Abiomed Inc shares in Q4 2015, an estimated $352K.
  • Reynolds Capital Management first reported a position in Abiomed Inc in Q3 2015 and held it in 1 quarter.
  • Reynolds Capital Management's Abiomed Inc position peaked at $352K in Q3 2015.
  • 249 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2015.

Based on Reynolds Capital Management's 13F filing for Q4 2015, filed 11 Jan 2016.